Vimarsana
Biggest News Aggregation in the World

Page 21 - Cell Proliferation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Proliferation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Proliferation Today - Breaking & Trending Today

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth - Vimarsana News

Optical imaging reveals how cancer cells hijack metabolic activity to fuel pancreatic tumor growth

Pancreatic cancer is a rare, yet elusive and deadly cancer, with a five-year survival rate of about 10%. If the cancer has metastasized, that rate lowers to 3%. And treatment options are extremely limited.

ProBioGen Announces Innovent as a New Partner Signing License of GlymaxX® Technology - Vimarsana News

ProBioGen Announces Innovent as a New Partner Signing License of GlymaxX® Technology

BERLIN, Germany, January 11, 2022 / B3C newswire / -- ProBioGen today announced that Innovent Biologics, Inc. (1801.HK) has signed a multi-product license for ProBioGen's GlymaxX technology.Under this license agreement, Innovent receives non-exclusive rights to use the afucosylation technology GlymaxX for multiple c...

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen's AGE1.CR® Vaccine Manufacturing Platform - Vimarsana News

Imvaq Therapeutics Signs a Service and Commercial Product License to Use ProBioGen's AGE1.CR® Vaccine Manufacturing Platform

BERLIN, Germany and NEW YORK, USA, January 06, 2022 / B3C newswire / -- ProBioGen AG is delighted to announce the execution of a service and commercial product license agreement with Imvaq Therapeutics, a biotech company developing innovative cancer immunotherapies. Under this agreement, ProBioGen develops a scalabl...

Researchers identify new mechanism that impairs cancer cell proliferation and induces death - Vimarsana News

Researchers identify new mechanism that impairs cancer cell proliferation and induces death

UAB and Vall d'Hebron researchers identified the mechanism by which inhibitors of the ERK5 protein kinase impair the proliferation of cancer cells and induce their death. The results, obtained using human cancer cell lines, demonstrate that ERK5 inhibition activates cytotoxic autophagy, a process that triggers cancer cell death, without affecting healthy cells. A combination of ERK5 inhibitors and chemotherapy could improve cancer treatment.

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension - Vimarsana News

Gene key to excessive cell proliferation could be a potential target for fatal pulmonary hypertension

A gene that is overexpressed in some aggressive cancers also appears to be key to the excessive cell proliferation that thickens the walls of pulmonary arteries and ultimately causes the right ventricle of the heart to fail, scientists report.